MK-8245 [1030612-90-8]
Referentie HY-13070-5mg
Formaat : 5mg
Merk : MedChemExpress
MK-8245 is a potent, liver-targeted stearoyl-CoA desaturase (SCD) inhibitor, with IC50s of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with antidiabetic and antidyslipidemic efficacy.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
MK-8245 Chemical Structure
CAS No. : 1030612-90-8
This product is a controlled substance and not for sale in your territory.
Based on 3 publication(s) in Google Scholar
Other Forms of MK-8245:
- MK-8245 Trifluoroacetate In-stock
Description |
MK-8245 is a potent, liver-targeted stearoyl-CoA desaturase (SCD) inhibitor, with IC50s of 1 nM for human SCD1 and 3 nM for both rat SCD1 and mouse SCD1, with antidiabetic and antidyslipidemic efficacy[1]. |
IC50 & Target |
IC50: 1 nM (human SCD1), 3 nM (rat SCD1), 3 nM (mouse SCD1)[1] |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
In Vitro |
MK-8245 is a potent and liver-specific SCD inhibitor[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||
In Vivo |
MK-8245 (10mg/kg; p.o.) exhibits a tissue distribution profile concentrated in the liver, with low exposure in tissues associated with potential adverse events in rats, dogs, and rhesus monkeys[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
|
||||||||||||
Essai clinique |
|
||||||||||||
Masse moléculaire |
467.25 |
||||||||||||
Formule |
C17H16BrFN6O4 |
||||||||||||
CAS No. |
1030612-90-8 |
||||||||||||
Appearance |
Solid |
||||||||||||
Color |
White to off-white |
||||||||||||
SMILES |
O=C(CN1N=C(N=N1)C2=CC(N3CCC(CC3)OC4=CC(F)=CC=C4Br)=NO2)O |
||||||||||||
Livraison | Room temperature in continental US; may vary elsewhere. |
||||||||||||
Stockage |
4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
||||||||||||
Solvant et solubilité |
In Vitro:
DMSO : ≥ 100 mg/mL (214.02 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) *"≥" means soluble, but saturation unknown. Preparing
Stock Solutions
View the Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol) Concentration (start) × Volume (start) = Concentration (final) × Volume (final) This equation is commonly abbreviated as: C1V1 = C2V2 In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
Dosage mg/kgAnimal weight Dosing volume Number of animals Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO
+
%
+
%
Tween-80
+
%
Saline
The co-solvents required include: DMSO,
. All of co-solvents are available by MedChemExpress (MCE).
, Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration:
mg/mL
Method for preparing stock solution:
mg
drug dissolved in
μL
DMSO (Stock solution concentration: mg/mL).
*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take
μL DMSO stock solution, add
μL .
μL , mix evenly, next add
μL Tween 80, mix evenly, then add
μL Saline.
If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
|
||||||||||||
Pureté et documentation |
Purity: 99.04% |
||||||||||||
Références |
|
Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
---|
DMSO | 1 mM | 2.1402 mL | 10.7009 mL | 21.4018 mL | 53.5045 mL |
5 mM | 0.4280 mL | 2.1402 mL | 4.2804 mL | 10.7009 mL | |
10 mM | 0.2140 mL | 1.0701 mL | 2.1402 mL | 5.3505 mL | |
15 mM | 0.1427 mL | 0.7134 mL | 1.4268 mL | 3.5670 mL | |
20 mM | 0.1070 mL | 0.5350 mL | 1.0701 mL | 2.6752 mL | |
25 mM | 0.0856 mL | 0.4280 mL | 0.8561 mL | 2.1402 mL | |
30 mM | 0.0713 mL | 0.3567 mL | 0.7134 mL | 1.7835 mL | |
40 mM | 0.0535 mL | 0.2675 mL | 0.5350 mL | 1.3376 mL | |
50 mM | 0.0428 mL | 0.2140 mL | 0.4280 mL | 1.0701 mL | |
60 mM | 0.0357 mL | 0.1783 mL | 0.3567 mL | 0.8917 mL | |
80 mM | 0.0268 mL | 0.1338 mL | 0.2675 mL | 0.6688 mL | |
100 mM | 0.0214 mL | 0.1070 mL | 0.2140 mL | 0.5350 mL |
MK-8245 Related Classifications
- Metabolic Enzyme/Protease
- Stearoyl-CoA Desaturase (SCD)